Financhill
Back

Plus Therapeutics 10K Form

Sell
25

PSTV
Plus Therapeutics

Last Price:
0.45
Seasonality Move:
-13.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PSTV News And Ratings

See the #1 stock for the next 7 days that we like better than PSTV

PSTV Financial Statistics

Sales & Book Value

Annual Sales: $300K
Cash Flow: $-2.78M
Price / Cash Flow: 0
Annual Sales: $0.43
Price / Book: 1.12

Profitability

EPS (TTM): -0.98000
Net Income (TTM): $-17.28M
Gross Margin: $5.51M
Return on Equity: 0%
Return on Assets: 0%

Plus Therapeutics Earnings Forecast

Key Plus Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 21 years for PSTV is 184.90%.
  • The Selling, General & Administrative Expenses for PSTV have been equal to 2,136.67% of Gross Profit Margin.
  • The Interest Expense is -6.94% of Operating Income.
  • Per Share Earnings over the last 24 years have been positive in 17 years.

Plus Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: PSTV
CUSIP: 72941H
Website: plustherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PSTV Technical Analysis vs Fundamental Analysis

Sell
25
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy or a Sell?

  • Plus Therapeutics stock is rated a Sell
    The current Plus Therapeutics [PSTV] share price is $0.48. The Score for PSTV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.